Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients / 医学前沿
Frontiers of Medicine
; (4): 621-628, 2021.
Article
in En
| WPRIM
| ID: wpr-888733
Responsible library:
WPRO
ABSTRACT
Multi-gene assays have emerged as crucial tools for risk stratification in early-stage breast cancer. This study aimed to evaluate the prognostic significance of the 21-gene recurrence score (RS) in Chinese patients with pN0-1, estrogen receptor-positive (ER
Key words
Full text:
1
Index:
WPRIM
Main subject:
Prognosis
/
Breast Neoplasms
/
Receptors, Estrogen
/
Biomarkers, Tumor
/
Receptor, ErbB-2
/
Neoplasm Recurrence, Local
/
Neoplasm Staging
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Frontiers of Medicine
Year:
2021
Type:
Article